Trial reportAnnals of family medicine2017
Delivery of Brief Interventions for Heavy Drinking in Primary Care: Outcomes of the ODHIN 5-Country Cluster Randomized Trial.
Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph
Trial report in Annals of family medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Technology-based mental healthcare models: A systematic review of the literature.Revista Colombiana de psiquiatria · 2021Pooled it
- A systematic review of approaches to improve practice, detection and treatment of unhealthy alcohol use in primary health care: a role for continuous quality improvement.BMC family practice · 2020Pooled it
- Supporting alcohol brief interventions and pharmacotherapy provision in Australian First Nations primary care: exploratory analysis of a cluster randomised trial.BMC primary care · 2024Trial
- Alcohol Screening and Brief Intervention in Primary Health Care in Kazakhstan-Results of a Cluster Randomised Pilot Study.International journal of public health · 2022Trial
- Impact of Training and Municipal Support on Primary Health Care-Based Measurement of Alcohol Consumption in Three Latin American Countries: 5-Month Outcome Results of the Quasi-experimental Randomized SCALA Trial.Journal of general internal medicine · 2021Trial
- Treating alcohol use disorders in primary care - a qualitative evaluation of a new innovation: the 15-method.Scandinavian journal of primary health care · 2021Trial
- Implementation of evidence-based alcohol policies to reduce alcohol-related harm and liver disease to advance public health in Europe.The Lancet regional health. Europe · 2026Review
- Lay counsellors' experiences of administering the AUDIT-C as a brief screening tool in a South African township.BMC health services research · 2023Article
- Development of community strategies supporting brief alcohol advice in three Latin American countries: a protocol.Health promotion international · 2023Article
- Estimated impact from the withdrawal of primary care financial incentives on selected indicators of quality of care in Scotland: controlled interrupted time series analysis.BMJ (Clinical research ed.) · 2023Article
- Danish feasibility study of a new innovation for treating alcohol disorders in primary care: the 15-method.BMC primary care · 2022Article
- Primary care implementation study to scale up early identification and brief intervention and reduce alcohol-related negative outcomes at the community level (PINO): study protocol for a quasi-experimental 3-arm study.BMC family practice · 2021Article
- Mental ill-health during COVID-19 confinement.BMC psychiatry · 2021Article
- Article
- Training health providers to address unhealthy alcohol use in primary care: a cross-sectional, multicenter study.BMC health services research · 2020Observational
- Financial reimbursement - irrelevant for GPs' readiness to implement brief intervention to reduce alcohol consumption? A cross-sectional vignette study.BMC family practice · 2020Article
- Feasibility of alcohol screening and brief intervention in primary health care in Kazakhstan: study protocol of a pilot cluster randomised trial.Pilot and feasibility studies · 2020Article
- Design and outcome measures for the AB InBev Global Smart Drinking Goals evaluation.Contemporary clinical trials communications · 2019Article
- Beliefs and attitudes about addressing alcohol consumption in health care: a population survey in England.BMC public health · 2018Article
- Now is the Time to Address Substance Use Disorders in Primary Care.Annals of family medicine · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Peter AndersonInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond). Peter.Anderson@newcastle.ac.uk.
Simon CoultonInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond).
Eileen KanerInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond).
Preben BendtsenInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond).
Karolina KłodaInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond).
Jillian ReynoldsInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond).
Lidia SeguraInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond).
Marcin WojnarInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond).
Artur MierzeckiInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond).
Paolo DelucaInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond).
Dorothy Newbury-BirchInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond).
Kathryn ParkinsonInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond).
Katarzyna Okulicz-KozarynInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond).
Colin DrummondInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond).
Antoni GualInstitute of Health and Society, Newcastle University, Newcastle, England (Anderson, Kaner, Parkinson); Department of Family Medicine, Maastricht University, Maastricht, the Netherlands (Anderson); Centre for Health Service Studies, University of Kent, Canterbury, England (Coulton); Department of Medical Specialist and Department of Medicine and Health, Linköping University, Motala, Sweden (Bendtsen); Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, Poland (Kłoda, Mierzecki); Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain (Reynolds, Gual); Program on Substance Abuse, Public Health Agency, Government of Catalonia, Barcelona, Spain (Segura); Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland (Wojnar); National Addiction Centre, Institute of Psychiatry, King's College London, London, England (Deluca, Drummond); Health and Social Care Institute, Teesside University, Middesbrough, United Kingdom (Newbury-Birch); State Agency for Prevention of Alcohol-Related Problems, Warsaw, Poland (Okulicz-Kozaryn); National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, England (Drummond).
Funding
Department of Health HTA/13/86/03Department of Health RP-PG-0609-10162Medical Research Council G0701681Medical Research Council G0701818Medical Research Council MR/K02325X/1
Abstract
purposeWe aimed to test whether 3 strategies-training and support, financial reimbursement, and an option to direct screen-positive patients to an Internet-based method of giving brief advice-have a longer-term effect on primary care clinicians' delivery of screening and advice to heavy drinkers operationalized with the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) tool.
methodsWe undertook a cluster randomized factorial trial with a 12-week implementation period in 120 primary health care units throughout Catalonia, England, Netherlands, Poland, and Sweden. Units were randomized to 8 groups: care as usual (control); training and support alone; financial reimbursement alone; electronic brief advice alone; paired combinations of these conditions; and all 3 combined. The primary outcome was the proportion of consulting adult patients (aged 18 years and older) receiving intervention-screening and, if screen-positive, advice-at 9 months.
resultsBased on the factorial design, the ratio of the log of the proportion of patients given intervention at the 9-month follow-up was 1.39 (95% CI, 1.03-1.88) in units that received training and support as compared with units that did not. Neither financial reimbursement nor directing screen-positive patients to electronic brief advice led to a higher proportion of patients receiving intervention.
conclusionsTraining and support of primary health care units has a lasting, albeit small, impact on the proportion of adult patients given an alcohol intervention at 9 months.
Indexed as
Reimbursement, IncentiveTraining SupportAdultAlcoholismEuropeFemaleHumansInternetMaleMiddle AgedPrimary Health Careelectronic brief interventionfinancial reimbursementheavy drinkingimplementation studypractice-based researchprimary health caretraining and support
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.